Advertisement
Home »

A novel Toll-like receptor 7/8-specific antagonist E6742 Ameliorates clinically relevant disease parameters in murine models of lupus.

Aug 07, 2023

ABOUT THE EXPERTS

  • Sally T Ishizaka

    Eisai Inc., Eisai Center for Genetics Guided Dementia Discovery, MA, USA.

    Lynn Hawkins

    Eisai Inc., Eisai Center for Genetics Guided Dementia Discovery, MA, USA.

    Qian Chen

    Eisai Inc., Eisai Center for Genetics Guided Dementia Discovery, MA, USA.

    Fumitoshi Tago

    Eisai Co., Ltd., Tokyo, Japan.

    Takuya Yagi

    Eisai Inc., NJ, USA.

    Kentaro Sakaniwa

    Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.

    Zhikuan Zhang

    Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.

    Toshiyuki Shimizu

    Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.

    Manabu Shirato

    Eisai Co., Ltd., Tsukuba Research Laboratories, Ibaraki, Japan. Electronic address: m-shirato@hhc.eisai.co.jp.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement